|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
Paclitaxel has been described to induce interleukin-8 (IL-8) transcription and secretion in human ovarian carcinoma cells. The objective of this study was to investigate possible clinical implications of the effect of paclitaxel on IL-8 serum levels in patients suffering from ovarian carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
388-93
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11180086-Adult,
pubmed-meshheading:11180086-Aged,
pubmed-meshheading:11180086-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11180086-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11180086-CA-125 Antigen,
pubmed-meshheading:11180086-Carboplatin,
pubmed-meshheading:11180086-Case-Control Studies,
pubmed-meshheading:11180086-Female,
pubmed-meshheading:11180086-Follow-Up Studies,
pubmed-meshheading:11180086-Humans,
pubmed-meshheading:11180086-Interleukin-8,
pubmed-meshheading:11180086-Middle Aged,
pubmed-meshheading:11180086-Neoplasm Proteins,
pubmed-meshheading:11180086-Ovarian Neoplasms,
pubmed-meshheading:11180086-Paclitaxel
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, University of Vienna Medical School, Vienna, Austria. klass.mayerhofer@akh-wien.ac.at
|
|
pubmed:publicationType |
Journal Article
|
